9.13
+0.38(+4.34%)
Currency In USD
Address
31 East 62nd Street
New York City, NY 10065
United States of America
Phone
212 672 9100
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
46
First IPO Date
September 10, 1997
| Name | Title | Pay | Year Born |
| Dr. Diem Nguyen M.B.A., Ph.D. | Chief Executive Officer & Director | 1.74M | 1972 |
| Mr. Lawrence R. Miller Esq., J.D. | General Counsel & Corporate Secretary | 1.01M | 1968 |
| Dr. Dennis E. Hruby Ph.D. | Executive Vice President & Chief Scientific Officer | 1.45M | 1952 |
| Mr. Daniel J. Luckshire CPA, M.B.A. | Executive Vice President, Chief Financial Officer & Secretary | 1.46M | 1971 |
| Ms. Tove C. Bolken | Senior Vice President of Operations & Chief Supply Chain Officer | 0 | N/A |
| Mr. Herb Vloedman | Senior Vice President & Chief Information Officer | 0 | N/A |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.